ARGININE VEYRON, oral solution in a vial bottle, 250 ml
Active ingredients: Arginine hydrochloride, L-arginine
Commercialized according to BDPM
Oral solutionbottle, 250 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARGININE VEYRON, solution buvable en flacon
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 250 ml
- Marketing authorisation holder
- PIERRE FABRE MEDICAMENT
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans le cas suivant :<br><br>- Hyperammoniémies congénitales ; JOURNAL OFFICIEL ; 28/02/14
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Oct 1961
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68869347CIP73006316CIP133400930063163Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| L-ARGININEsolution | 13,5562 g · 100 g de solution buvable | FT |
| CHLORHYDRATE DE L-ARGININEsolution | 16,4000 g · 100 g de solution buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.